Rituxan (rituximab) - Roche
prednisone - Generic mfg.
atovaquone - Generic mfg.
Pauci-Immune Crescentic Glomerulonephritis in the Setting of ANCA Positivity and Late Latent Syphilis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0796; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Given prior hepatitis B exposure, tenofovir and atovaquone prophylaxis were initiated before immunosuppression. The case was further complicated by worsening renal function despite chronic prednisone use and prior hepatitis B exposure, requiring antiviral prophylaxis before rituximab therapy. This case highlights the essential role of kidney biopsy in distinguishing infection-related glomerulonephritis from ANCA-associated vasculitis and emphasizes careful infectious evaluation before long-term immunosuppression." 
ANCA Vasculitis • Benign Prostatic Hyperplasia • Chronic Kidney Disease • Fibrosis • Glomerulonephritis • Hepatitis B • Hepatology • Immunology • Infectious Disease • Inflammation • Interstitial Lung Disease • Lupus Nephritis • Nephrology • Pneumonia • Pulmonary Disease • Renal Disease • Respiratory Diseases • Vasculitis
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559249
 
Amna Anwar; Omar A. Elrefy; Daranee Chewaproug; Zahoor Ahmed
 
Oct 2, 2026
 
Prev Next